Skip to content

Insider · CIK 0001551817

H. Lawrence Remmel

director

Files at ATOS (ATOSSA THERAPEUTICS, INC.). First filing Mar 28, 2025, latest Mar 28, 2025.

H. Lawrence Remmel files SEC Form 4 as director at ATOS (ATOSSA THERAPEUTICS, INC.). Since Mar 28, 2025, H. Lawrence Remmel has reported 1 open-market buy worth $7,000 and 0 open-market sells worth $0, the latest filed on Mar 28, 2025.

A track record needs three past buys with six months of prices behind them; H. Lawrence Remmel has 0, so none is measured yet.

The newest scored trade: bought $7,000 of ATOS on Mar 26, 2025, filed Mar 28, 2025, scored 25 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$7,000 bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ATOS: ATOSSA THERAPEUTICS, INC.

ATOSOct 9, 2026 · close 2.44

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
25Weak
ATOSbuy
ATOSSA THERAPEUTICS, INC.
$7,000
10,000 shares
+3891%-

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 12, 2026ATOS
ATOSSA THERAPEUTICS, INC.
AGrant or award
Common Stock
+10,000$0.00$010,683May 14, 2026
May 15, 2025ATOS
ATOSSA THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy)derivative
+125,000$0.00$0125,000May 16, 2025
Mar 26, 2025ATOS
ATOSSA THERAPEUTICS, INC.
POpen-market purchase
Common Stock
+10,000$0.70$7,00010,257Mar 28, 2025

Questions about H. Lawrence Remmel

Answered from the filings on this page, as of the latest one.

Is H. Lawrence Remmel buying or selling?

Not in the last 12 months. H. Lawrence Remmel's latest open-market trade on SEC Form 4 was bought $7,000 of ATOS on Mar 26, 2025.

How did H. Lawrence Remmel's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and H. Lawrence Remmel has 0.

Where does H. Lawrence Remmel file Form 4?

H. Lawrence Remmel has filed Form 4 at ATOS (ATOSSA THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

H. Lawrence Remmel: insider trades and track record | InsiderTell